Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Risk Factors for Surgical Site Infections After Orthopaedic Surgery in the Ambulatory Surgical Center Setting.

Brophy RH, Bansal A, Rogalski BL, Rizzo MG, Weiner EJ, Wolff BD, Goldfarb CA.

J Am Acad Orthop Surg. 2018 Dec 31. doi: 10.5435/JAAOS-D-17-00861. [Epub ahead of print]

PMID:
30608278
2.

Complications Following Overlapping Orthopaedic Procedures at an Ambulatory Surgery Center.

Goldfarb CA, Rizzo MG, Rogalski BL, Bansal A, Dy CJ, Brophy RH.

J Bone Joint Surg Am. 2018 Dec 19;100(24):2118-2124. doi: 10.2106/JBJS.18.00244.

PMID:
30562292
3.

Phage-based assay for rapid detection of bacterial pathogens in blood by Raman spectroscopy.

De Plano LM, Fazio E, Rizzo MG, Franco D, Carnazza S, Trusso S, Neri F, Guglielmino SPP.

J Immunol Methods. 2018 Dec 12. pii: S0022-1759(18)30386-7. doi: 10.1016/j.jim.2018.12.004. [Epub ahead of print]

PMID:
30552870
4.

Does DRG funding encourage hospital specialization? Evidence from the Italian National Health Service.

Anessi-Pessina E, Nieddu L, Rizzo MG.

Int J Health Plann Manage. 2018 Dec 5. doi: 10.1002/hpm.2715. [Epub ahead of print]

PMID:
30516293
5.

Examining the role of value congruence, professional identity, and managerial job engagement in the budgetary participation-performance link.

Macinati MS, Nieddu L, Rizzo MG.

Health Care Manage Rev. 2018 Nov 20. doi: 10.1097/HMR.0000000000000231. [Epub ahead of print]

PMID:
30475259
6.

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.

D'Aguanno S, Valentini E, Tupone MG, Desideri M, Di Martile M, Spagnuolo M, Buglioni S, Ercolani C, Falcone I, De Dominici M, Milella M, Rizzo MG, Calabretta B, Cota C, Anichini A, Trisciuoglio D, Del Bufalo D.

J Exp Clin Cancer Res. 2018 Nov 19;37(1):278. doi: 10.1186/s13046-018-0933-x.

7.

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.

Spagnuolo M, Regazzo G, De Dominici M, Sacconi A, Pelosi A, Korita E, Marchesi F, Pisani F, Magenta A, Lulli V, Cordone I, Mengarelli A, Strano S, Blandino G, Rizzo MG, Calabretta B.

Haematologica. 2019 Jan;104(1):82-92. doi: 10.3324/haematol.2018.191213. Epub 2018 Aug 3.

8.

Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.

Marchesi F, Regazzo G, Palombi F, Terrenato I, Sacconi A, Spagnuolo M, Donzelli S, Marino M, Ercolani C, Di Benedetto A, Blandino G, Ciliberto G, Mengarelli A, Rizzo MG.

J Exp Clin Cancer Res. 2018 May 2;37(1):95. doi: 10.1186/s13046-018-0768-5.

9.

Quality improvement strategies and tools: A comparative analysis between Italy and the United States.

Villa S, Restuccia JD, Anessi-Pessina E, Rizzo MG, Cohen AB.

Health Serv Manage Res. 2018 Nov;31(4):205-217. doi: 10.1177/0951484818755534. Epub 2018 Feb 27.

PMID:
29486603
10.

Biosynthesis and structural characterization of polyhydroxyalkanoates produced by Pseudomonas aeruginosa ATCC 27853 from long odd-chain fatty acids.

Impallomeni G, Ballistreri A, Carnemolla GM, Rizzo MG, Nicolò MS, Guglielmino SPP.

Int J Biol Macromol. 2018 Mar;108:608-614. doi: 10.1016/j.ijbiomac.2017.12.037. Epub 2017 Dec 6.

PMID:
29223758
11.

Specific and selective probes for Staphylococcus aureus from phage-displayed random peptide libraries.

De Plano LM, Carnazza S, Messina GML, Rizzo MG, Marletta G, Guglielmino SPP.

Colloids Surf B Biointerfaces. 2017 Sep 1;157:473-480. doi: 10.1016/j.colsurfb.2017.05.081. Epub 2017 Jun 17.

PMID:
28654884
12.

Carbon source effects on the mono/dirhamnolipid ratio produced by Pseudomonas aeruginosa L05, a new human respiratory isolate.

Nicolò MS, Cambria MG, Impallomeni G, Rizzo MG, Pellicorio C, Ballistreri A, Guglielmino SPP.

N Biotechnol. 2017 Oct 25;39(Pt A):36-41. doi: 10.1016/j.nbt.2017.05.013. Epub 2017 Jun 3.

PMID:
28587884
13.

Medical managers' managerial self-efficacy and role clarity: How do they bridge the budgetary participation-performance link?

Macinati MS, Cantaluppi G, Rizzo MG.

Health Serv Manage Res. 2017 Feb;30(1):47-60. doi: 10.1177/0951484816682398. Epub 2016 Dec 22.

PMID:
28166674
14.

Fatty acid synthesis configures the plasma membrane for inflammation in diabetes.

Wei X, Song H, Yin L, Rizzo MG, Sidhu R, Covey DF, Ory DS, Semenkovich CF.

Nature. 2016 Nov 10;539(7628):294-298. doi: 10.1038/nature20117. Epub 2016 Nov 2.

15.

The laminA/NF-Y protein complex reveals an unknown transcriptional mechanism on cell proliferation.

Cicchillitti L, Manni I, Mancone C, Regazzo G, Spagnuolo M, Alonzi T, Carlomosti F, Dell'Anna ML, Dell'Omo G, Picardo M, Ciana P, Capogrossi MC, Tripodi M, Magenta A, Rizzo MG, Gurtner A, Piaggio G.

Oncotarget. 2017 Jan 10;8(2):2628-2646. doi: 10.18632/oncotarget.12914.

16.

Budgetary participation and performance: The mediating effects of medical managers' job engagement and self-efficacy.

Macinati MS, Bozzi S, Rizzo MG.

Health Policy. 2016 Sep;120(9):1017-28. doi: 10.1016/j.healthpol.2016.08.005. Epub 2016 Aug 22.

PMID:
27593950
17.

A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.

Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.

J Exp Clin Cancer Res. 2016 Jul 30;35(1):124. doi: 10.1186/s13046-016-0393-0.

18.

The role of glutamine in Pseudomonas mediterranea in biotechnological processes.

Rizzo MG, Chines V, Franco D, Nicolò MS, Guglielmino SP.

N Biotechnol. 2017 Jul 25;37(Pt A):144-151. doi: 10.1016/j.nbt.2016.04.005. Epub 2016 Apr 25.

PMID:
27126474
19.

miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.

De Luca T, Pelosi A, Trisciuoglio D, D'Aguanno S, Desideri M, Farini V, Di Martile M, Bellei B, Tupone MG, Candiloro A, Regazzo G, Rizzo MG, Del Bufalo D.

Mol Carcinog. 2016 Dec;55(12):2304-2312. doi: 10.1002/mc.22437. Epub 2015 Nov 24.

PMID:
26599548
20.

Exploring the link between clinical managers involvement in budgeting and performance: Insights from the Italian public health care sector.

Macinati MS, Rizzo MG.

Health Care Manage Rev. 2016 Jul-Sep;41(3):213-23. doi: 10.1097/HMR.0000000000000071.

PMID:
26052784
21.

Budget goal commitment, clinical managers' use of budget information and performance.

Macinati MS, Rizzo MG.

Health Policy. 2014 Aug;117(2):228-38. doi: 10.1016/j.healthpol.2014.05.003. Epub 2014 May 28.

PMID:
24929475
22.

Dual promoter usage as regulatory mechanism of let-7c expression in leukemic and solid tumors.

Pelosi A, Careccia S, Sagrestani G, Nanni S, Manni I, Schinzari V, Martens JH, Farsetti A, Stunnenberg HG, Gentileschi MP, Del Bufalo D, De Maria R, Piaggio G, Rizzo MG.

Mol Cancer Res. 2014 Jun;12(6):878-89. doi: 10.1158/1541-7786.MCR-13-0410. Epub 2014 Mar 17.

23.

BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.

Gabellini C, De Luca T, Trisciuoglio D, Desideri M, Di Martile M, Passeri D, Candiloro A, Biffoni M, Rizzo MG, Orlandi A, Del Bufalo D.

Carcinogenesis. 2013 Nov;34(11):2558-67. doi: 10.1093/carcin/bgt242. Epub 2013 Jul 8.

PMID:
23836782
24.

miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia.

Pelosi A, Careccia S, Lulli V, Romania P, Marziali G, Testa U, Lavorgna S, Lo-Coco F, Petti MC, Calabretta B, Levrero M, Piaggio G, Rizzo MG.

Oncogene. 2013 Aug 1;32(31):3648-54. doi: 10.1038/onc.2012.398. Epub 2012 Sep 10.

PMID:
22964640
25.

CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.

Trisciuoglio D, Ragazzoni Y, Pelosi A, Desideri M, Carradori S, Gabellini C, Maresca G, Nescatelli R, Secci D, Bolasco A, Bizzarri B, Cavaliere C, D'Agnano I, Filetici P, Ricci-Vitiani L, Rizzo MG, Del Bufalo D.

Clin Cancer Res. 2012 Jan 15;18(2):475-86. doi: 10.1158/1078-0432.CCR-11-0579. Epub 2011 Nov 8.

26.

A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.

Careccia S, Mainardi S, Pelosi A, Gurtner A, Diverio D, Riccioni R, Testa U, Pelosi E, Piaggio G, Sacchi A, Lavorgna S, Lo-Coco F, Blandino G, Levrero M, Rizzo MG.

Oncogene. 2009 Nov 12;28(45):4034-40. doi: 10.1038/onc.2009.255. Epub 2009 Sep 14.

PMID:
19749800
27.

The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

Manni I, Artuso S, Careccia S, Rizzo MG, Baserga R, Piaggio G, Sacchi A.

FASEB J. 2009 Nov;23(11):3957-66. doi: 10.1096/fj.09-131847. Epub 2009 Jul 16.

PMID:
19608627
28.

deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation.

Mainardi S, Pelosi A, Palescandolo E, Riccioni R, Fontemaggi G, Diverio D, Testa U, Sacchi A, Grignani F, Lo-Coco F, Levrero M, Blandino G, Rizzo MG.

Cell Death Differ. 2007 Nov;14(11):1968-71. Epub 2007 Aug 10. No abstract available.

29.

Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.

Ziermann R, Celis L, Derdelinckx I, Lambert C, Veeck J, Rizzo MG, Vanderborght B, Zissis G, Clumeck N, Fransen K, Vaira D, Hendricks D, Van Laethem K, Vandamme AM, Schmit JC, Knechten H, De Luca A, Louwagie J, Segers P, De Boeck K, Pottel H, De Brauwer A, Hulstaert F.

J Clin Virol. 2004 Dec;31 Suppl 1:S7-15.

30.

Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia.

Rizzo MG, Giombini E, Diverio D, Vignetti M, Sacchi A, Testa U, Lo-Coco F, Blandino G.

Leukemia. 2004 Nov;18(11):1804-9.

PMID:
15385938
31.

Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells.

Acosta JC, Richard C, Delgado MD, Horita M, Rizzo MG, Fernández-Luna JL, León J.

Mol Cancer Ther. 2003 Sep;2(9):893-900.

32.

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.

De Luca A, Cingolani A, Di Giambenedetto S, Trotta MP, Baldini F, Rizzo MG, Bertoli A, Liuzzi G, Narciso P, Murri R, Ammassari A, Perno CF, Antinori A.

J Infect Dis. 2003 Jun 15;187(12):1934-43. Epub 2003 May 22.

PMID:
12792870
33.

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

Antinori A, Zaccarelli M, Cingolani A, Forbici F, Rizzo MG, Trotta MP, Di Giambenedetto S, Narciso P, Ammassari A, Girardi E, De Luca A, Perno CF.

AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):835-8.

PMID:
12201905
34.

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.

De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, Giancola ML, Ammassari A, Ortona L.

Neurology. 2002 Aug 13;59(3):342-7.

PMID:
12177366
35.

Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

Strano S, Fontemaggi G, Costanzo A, Rizzo MG, Monti O, Baccarini A, Del Sal G, Levrero M, Sacchi A, Oren M, Blandino G.

J Biol Chem. 2002 May 24;277(21):18817-26. Epub 2002 Mar 13.

36.

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

Cingolani A, Antinori A, Rizzo MG, Murri R, Ammassari A, Baldini F, Di Giambenedetto S, Cauda R, De Luca A.

AIDS. 2002 Feb 15;16(3):369-79.

PMID:
11834948
37.

Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy.

Antinori A, Liuzzi G, Cingolani A, Bertoli A, Di Giambenedetto S, Trotta MP, Rizzo MG, Girardi E, De Luca A, Perno CF.

AIDS. 2001 Nov 23;15(17):2325-7. No abstract available.

PMID:
11698709
38.

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.

Antinori A, Baldini F, Girardi E, Cingolani A, Zaccarelli M, Di Giambenedetto S, Barracchini A, De Longis P, Murri R, Tozzi V, Ammassari A, Rizzo MG, Ippolito G, De Luca A.

AIDS. 2001 Aug 17;15(12):1579-81.

PMID:
11504993
39.

Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras.

Cristofanelli B, Valentinis B, Soddu S, Rizzo MG, Marchetti A, Bossi G, Morena AR, Dews M, Baserga R, Sacchi A.

Oncogene. 2000 Jul 6;19(29):3245-55.

40.

Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation.

Rizzo MG, Zepparoni A, Cristofanelli B, Scardigli R, Crescenzi M, Blandino G, Giuliacci S, Ferrari S, Soddu S, Sacchi A.

Br J Cancer. 1998 May;77(9):1429-38.

41.
42.

Interference with p53 protein inhibits hematopoietic and muscle differentiation.

Soddu S, Blandino G, Scardigli R, Coen S, Marchetti A, Rizzo MG, Bossi G, Cimino L, Crescenzi M, Sacchi A.

J Cell Biol. 1996 Jul;134(1):193-204.

43.

Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes.

Soddu S, Blandino G, Scardigli R, Martinelli R, Rizzo MG, Crescenzi M, Sacchi A.

Mol Cell Biol. 1996 Feb;16(2):487-95.

44.

Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells.

Blandino G, Scardigli R, Rizzo MG, Crescenzi M, Soddu S, Sacchi A.

Oncogene. 1995 Feb 16;10(4):731-7.

PMID:
7862450
45.

Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants.

Rizzo MG, Soddu S, Tibursi G, Calabretta B, Sacchi A.

Clin Exp Metastasis. 1993 Sep;11(5):368-76.

PMID:
8375112
46.

Sequence of a cDNA encoding the beta 4 subunit of murine integrin.

Kennel SJ, Foote LJ, Cimino L, Rizzo MG, Chang LY, Sacchi A.

Gene. 1993 Aug 25;130(2):209-16.

PMID:
8359687
47.

Hemostasis and platelet aggregation in purpuric pigmented angiodermatitis eruptions.

Vignale R, Rizzo MG.

Int J Dermatol. 1992 Nov;31(11):786-8.

PMID:
1428430
48.

The promoter of the proliferating cell nuclear antigen (PCNA) gene is active in serum-derived cells.

Ottavio L, Chang CD, Rizzo MG, Petralia S, Travali S, Baserga R.

Biochem Biophys Res Commun. 1990 Jun 15;169(2):509-16.

PMID:
1694073
49.

The promoter of the human proliferating cell nuclear antigen (PCNA) gene is bidirectional.

Rizzo MG, Ottavio L, Travali S, Chang CD, Kaminska B, Baserga R.

Exp Cell Res. 1990 Jun;188(2):286-93.

PMID:
1970785
50.

Importance of introns in the growth regulation of mRNA levels of the proliferating cell nuclear antigen gene.

Ottavio L, Chang CD, Rizzo MG, Travali S, Casadevall C, Baserga R.

Mol Cell Biol. 1990 Jan;10(1):303-9.

Supplemental Content

Loading ...
Support Center